LIFEVANTAGE CORP Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-11-28: Form PRE 14A; Period of report 2017-11-28; Description PRE 14A; Document preliminaryproxystatementf.htm.
- 2015-09-01: Form PRE 14A; Period of report 2015-10-15; Description PRE 14A; Document proxystatementfy2016.htm.
- 2006-10-06: Form PRE 14A; Period of report 2006-11-21; Description PRELIMINARY PROXY STATEMENT; Document d40108pre14a.htm.
- 2004-06-01: Form PRE 14A; Period of report 2004-05-28; Description Preliminary proxy statement; Document yaakpre14a.txt.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2017-11-28 | PRE 14A | 2017-11-28 | PRE 14A | preliminaryproxystatementf.htm |
| 2015-09-01 | PRE 14A | 2015-10-15 | PRE 14A | proxystatementfy2016.htm |
| 2006-10-06 | PRE 14A | 2006-11-21 | PRELIMINARY PROXY STATEMENT | d40108pre14a.htm |
| 2004-06-01 | PRE 14A | 2004-05-28 | Preliminary proxy statement | yaakpre14a.txt |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |